Literature DB >> 25189821

Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia.

Hussnain Mirza1, James Ziegler2, Sara Ford2, James Padbury1, Richard Tucker1, Abbot Laptook3.   

Abstract

OBJECTIVE: To determine whether early pulmonary hypertension (PH) at 10-14 days of life in preterm infants is associated with bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA). STUDY
DESIGN: This was a prospective observational cohort study of infants <28 weeks' gestation. Exclusion criteria were any major anomaly, genetic syndrome, or death before the initial echocardiogram. Echocardiograms were performed between 10 and 14 days of life and at 36 weeks' PMA to assess PH. BPD and its severity were determined at 36 weeks PMA by the National Institutes of Health workshop definition.
RESULTS: From March 2011 to April 2013, of 146 consecutively admitted infants <28 weeks, 120 were enrolled. One infant was excluded, 17 did not consent, and 8 died before undergoing a study echocardiogram. At 10-14 days of life, 10 infants had early PH (8%). Male sex (56% vs 40%), gestational age (26(+2) ± 1(+2) vs 25(+6) ± 1(+4) weeks), birth weight (837 ± 205 g vs 763 ± 182 g), and small for gestational age (14% vs 20%) were not significantly different among infants with no PH and early PH, respectively. Infants with early PH required >0.3 fraction of inspired oxygen by day 10 of life (70% vs 27%, P < .01). Moderate/severe BPD or death was greater among infants with early PH (90%) compared with no PH (47%, relative risk 1.9, 95% CI 1.43-2.53).
CONCLUSION: In this prospective, single-center cohort, early PH was associated with moderate/severe BPD or death at 36 weeks' PMA.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25189821     DOI: 10.1016/j.jpeds.2014.07.040

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  51 in total

1.  Pulmonary hypertension in premature infants. Sharpening the tools of detection.

Authors:  Kathryn N Farrow; Robin H Steinhorn
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

Review 2.  Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

Authors:  G Al-Ghanem; P Shah; S Thomas; L Banfield; S El Helou; C Fusch; A Mukerji
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

3.  Cardiac Magnetic Resonance Imaging Evaluation of Neonatal Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.

Authors:  Paul J Critser; Nara S Higano; Jean A Tkach; Emilia S Olson; David R Spielberg; Paul S Kingma; Robert J Fleck; Sean M Lang; Ryan A Moore; Michael D Taylor; Jason C Woods
Journal:  Am J Respir Crit Care Med       Date:  2020-01-01       Impact factor: 21.405

4.  Association of unit-wide oxygen saturation target on incidence of pulmonary hypertension in very low birthweight premature infants.

Authors:  U Kanaan; B Srivatsa; J Huckaby; M Kelleman
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

5.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; Joshua I Miller; John P Kinsella; Christopher D Baker; Brenda B Poindexter; David A Ingram; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

6.  Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia.

Authors:  Katherine Y Wu; Erik A Jensen; Ammie M White; Yan Wang; David M Biko; Kathleen Nilan; María V Fraga; Laura Mercer-Rosa; Huayan Zhang; Haresh Kirpalani
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

7.  Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?

Authors:  Praveen Chandrasekharan; Rafal Kozielski; Vasantha H S Kumar; Munmun Rawat; Veena Manja; Changxing Ma; Satyan Lakshminrusimha
Journal:  Am J Perinatol       Date:  2016-09-14       Impact factor: 1.862

8.  Association of Oxygen Target and Growth Status With Increased Mortality in Small for Gestational Age Infants: Further Analysis of the Surfactant, Positive Pressure and Pulse Oximetry Randomized Trial.

Authors:  Michele C Walsh; Juliann M Di Fiore; Richard J Martin; Marie Gantz; Waldemar A Carlo; Neil Finer
Journal:  JAMA Pediatr       Date:  2016-03       Impact factor: 16.193

Review 9.  Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.

Authors:  Peter M Mourani; Steven H Abman
Journal:  Clin Perinatol       Date:  2015-09-26       Impact factor: 3.430

10.  Arginase and α-smooth muscle actin induction after hyperoxic exposure in a mouse model of bronchopulmonary dysplasia.

Authors:  Jennifer K Trittmann; Markus Velten; Kathryn M Heyob; Hanadi Almazroue; Yi Jin; Leif D Nelin; Lynette K Rogers
Journal:  Clin Exp Pharmacol Physiol       Date:  2018-02-06       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.